ESC 365 - Impact of low-surgical-risk TAVI trials on clinical decision making

ESC Premium Access

Impact of low-surgical-risk TAVI trials on clinical decision making

Event: ESC CONGRESS 2019

Topic: Diseases of the Aorta

Session type: Satellite Symposium

Sponsored by Medscape Education Global

Date: 1 September 2019

Time: 18:15 - 19:00

Session

6 presentations in this session

Welcome and introductions

Speaker: Professor L. Pierard (Liege, BE)

Asymptomatic patients at risk with severe aortic stenosis

Speaker: Professor L. Pierard (Liege, BE)

Clinical case - A low surgical risk patient undergoing TAVI

Speaker: Professor T. Modine (Lille, FR)

Do valve hemodynamic function and durability matter?

Speaker: Professor P. Pibarot (Quebec, CA)

What is the impact on clinical practice of low-risk TAVI trials?

Speaker: Associate Professor G. Tarantini (Padua, IT)

Questions and answers and panel discussion

Speaker: Professor L. Pierard (Liege, BE)

6 speakers from this session

Professor Luc Pierard

University of Liege, Liege (Belgium)

15 presentations

0 follower

Professor Luc Pierard

University of Liege, Liege (Belgium)

15 presentations

0 follower

Professor Thomas Modine

CHRU Lille, Lille (France)

5 presentations

0 follower

Professor Philippe Pibarot

Quebec Heart and Lung Institute, Quebec (Canada)

25 presentations

0 follower

Associate Professor Giuseppe Tarantini

University Hospital of Padova, Padua (Italy)

8 presentations

1 follower

Professor Luc Pierard

University of Liege, Liege (Belgium)

15 presentations

0 follower

This platform is supported by